David Spetzler

17PUBLICATIONS
211CO-AUTHORS
Predictive and prognostic markersMolecular targetsLiquid biopsiesEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 13, 2026
Differential impact of tumor-derived ESR1 mutations on elacestrant benefit in metastatic breast cancer.

|Oct 09, 2026
The conformation-selective PI3Kδ inhibitor roginolisib in patients with advanced or metastatic cancer, including metastatic uveal melanoma: first-in-human clinical trial.

|Jul 17, 2026
Development and Validation of a Multimodal-Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer.

|Jan 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.

Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto

|Aug 01, 2025
Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer.

Yating Cheng, Norsang Lama, Ming Chen

|Jul 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.

Hassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro

Pageof 3

Frequent Collaborators

12 joint publications

Matthew Oberley

10 joint publications

George W Sledge

9 joint publications

Jennifer R Ribeiro

8 joint publications

Milan Radovich